HLA Genotype and Carbamazepine-Induced Cutaneous Adverse Drug Reactions: A Systematic Review
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
HLA Genotype and Carbamazepine-Induced Cutaneous Adverse Drug Reactions: A Systematic Review
Authors
Keywords
-
Journal
CLINICAL PHARMACOLOGY & THERAPEUTICS
Volume 92, Issue 6, Pages 757-765
Publisher
Springer Nature
Online
2012-11-07
DOI
10.1038/clpt.2012.189
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Phenotype Standardization for Immune-Mediated Drug-Induced Skin Injury
- (2011) M Pirmohamed et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Carbamazepine-induced severe cutaneous adverse reactions and HLA genotypes in Koreans
- (2011) Sae-Hoon Kim et al. EPILEPSY RESEARCH
- Strong association between HLA-B*1502 and carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in mainland Han Chinese patients
- (2011) Yan Zhang et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Association of HLA-B*1502 allele with carbamazepine-induced toxic epidermal necrolysis and Stevens-Johnson syndrome in the multi-ethnic Malaysian population
- (2011) Choong-Chor Chang et al. INTERNATIONAL JOURNAL OF DERMATOLOGY
- Drug hypersensitivity: Pharmacogenetics and clinical syndromes
- (2011) Elizabeth J. Phillips et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Carbamazepine-Induced Toxic Effects and HLA-B*1502 Screening in Taiwan
- (2011) Pei Chen et al. NEW ENGLAND JOURNAL OF MEDICINE
- HLA-A*3101 and Carbamazepine-Induced Hypersensitivity Reactions in Europeans
- (2011) Mark McCormack et al. NEW ENGLAND JOURNAL OF MEDICINE
- Association between HLA-B*1502 allele and carbamazepine-induced severe cutaneous adverse reactions in Han people of southern China mainland
- (2011) Qian Wang et al. SEIZURE-EUROPEAN JOURNAL OF EPILEPSY
- HLA-B*1502 Strongly Predicts Carbamazepine-Induced Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Thai Patients with Neuropathic Pain
- (2011) Kongkiat Kulkantrakorn et al. Pain Practice
- HLA-B* 1502 screening: Time to clinical practice
- (2010) Chaichon Locharernkul et al. EPILEPSIA
- HLA-B*1511 is a risk factor for carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Japanese patients
- (2010) Nahoko Kaniwa et al. EPILEPSIA
- Association between HLA-B*1502 and carbamazepine-induced severe cutaneous adverse drug reactions in a Thai population
- (2010) Wichittra Tassaneeyakul et al. EPILEPSIA
- Association between carbamazepine-induced cutaneous adverse drug reactions and the HLA-B*1502 allele among patients in central China
- (2010) X.T. Wu et al. EPILEPSY & BEHAVIOR
- Genome-wide association study identifies HLA-A*3101 allele as a genetic risk factor for carbamazepine-induced cutaneous adverse drug reactions in Japanese population
- (2010) Takeshi Ozeki et al. HUMAN MOLECULAR GENETICS
- Human leukocyte antigen genotypes in carbamazepine-induced severe cutaneous adverse drug response in Japanese patients
- (2010) Mariko KASHIWAGI et al. JOURNAL OF DERMATOLOGY
- HLA Class I markers in Japanese patients with carbamazepine-induced cutaneous adverse reactions
- (2009) Hiroko Ikeda et al. EPILEPSIA
- Association of HLA-BFNx011502 allele and carbamazepine-inducedStevens-Johnson syndromeamong Indians
- (2009) TimirY Mehta et al. Indian Journal of Dermatology Venereology & Leprology
- Carbamazepine and phenytoin induced Stevens-Johnson syndrome is associated with HLA-B*1502 allele in Thai population
- (2008) Chaichon Locharernkul et al. EPILEPSIA
- HLA-B locus in Japanese patients with anti-epileptics and allopurinol-related Stevens–Johnson syndrome and toxic epidermal necrolysis
- (2008) Nahoko Kaniwa et al. PHARMACOGENOMICS
- Carbamazepine,HLA-B*1502and risk of Stevens–Johnson syndrome and toxic epidermal necrolysis: US FDA recommendations
- (2008) P Brent Ferrell et al. PHARMACOGENOMICS
- Methodological quality of pharmacogenetic studies: Issues of concern
- (2008) Andrea L. Jorgensen et al. STATISTICS IN MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation